Transforming Cancer Treatment: The Rise of Precision Medicine and Innovative Startups
The integration of precision medicine is revolutionizing cancer treatment, particularly in developed countries like the US and UK. Startups such as Creasallis and Concr are leading the way in developing targeted therapies and innovative analytical tools, significantly improving patient outcomes and addressing ongoing challenges in oncology. Discover how these pioneers are shaping the future of cancer care.
New Blood Test Detects Early Lung Damage in Cancer Patients on Targeted Therapy
A revolutionary blood test developed by researchers at Hadassah Medical Center detects early lung damage in cancer patients receiving antibody-drug conjugates (ADCs). This non-invasive method offers a timely alternative to traditional imaging, improving patient outcomes and safety by allowing for early intervention in cases of interstitial lung disease (ILD).